Literature DB >> 9665007

Differential effects of cyclosporin A and tacrolimus on the production of TGF-beta: implications for the development of obliterative bronchiolitis after lung transplantation.

J G Zhang1, M W Walmsley, J V Moy, A C Cunningham, D Talbot, J H Dark, J A Kirby.   

Abstract

The development of obliterative bronchiolitis is a common cause for failure of lung allografts. Fibrinogenesis can occur for a number of different reasons but some groups have suggested that cyclosporin A (CsA) and tacrolimus (FK506) have different effects on the cytokines which induce fibrinogenesis. We investigated the effect of tacrolimus and CsA in tissue culture and found that there was indeed a negative effect on human lung small airway epithelial cell proliferation by recombinant transforming growth factor-beta (TGF-beta), which was reversed by anti-TGF-beta. The same effect was seen with CsA at immunosuppressive concentrations, which was also reversed by anti-TGF-beta, whereas no such inhibition was seen with tacrolimus at immunosuppressive doses unless high concentrations were used. Free TGF-beta was confirmed as being elevated in the supernatant of cell culture wells with standard dose CsA as opposed to low dose CsA or tacrolimus using an ELISA assay.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665007     DOI: 10.1007/s001470050489

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  7 in total

Review 1.  Functional role of cellular senescence in biliary injury.

Authors:  Luke Meng; Morgan Quezada; Phillip Levine; Yuyan Han; Kelly McDaniel; Tianhao Zhou; Emily Lin; Shannon Glaser; Fanyin Meng; Heather Francis; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2015-01-22       Impact factor: 4.307

2.  Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs.

Authors:  J G Lunz; S Contrucci; K Ruppert; N Murase; J J Fung; T E Starzl; A J Demetris
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

3.  Synergy of Transforming Growth Factor Beta 1 and All Trans Retinoic Acid in the Treatment of Inflammatory Bowel Disease: Role of Regulatory T cells.

Authors:  Dominick L Auci; Nejat K Egilmez
Journal:  J Gastroenterol Pancreatol Liver Disord       Date:  2016-08-11

4.  Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease.

Authors:  Thomas F Conway; Laura Hammer; Stacia Furtado; Edith Mathiowitz; Ferdinando Nicoletti; Katia Mangano; Nejat K Egilmez; Dominick L Auci
Journal:  J Crohns Colitis       Date:  2015-05-18       Impact factor: 9.071

5.  Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.

Authors:  K Blakolmer; A Jain; K Ruppert; E Gray; R Duquesnoy; N Murase; T E Starzl; J J Fung; A J Demetris
Journal:  Transplantation       Date:  2000-06-15       Impact factor: 4.939

6.  Differentiated transplant derived airway epithelial cell cytokine secretion is not regulated by cyclosporine.

Authors:  Timothy Floreth; Eric Stern; Yingli Tu; Randi Stern; Edward R Garrity; Sangeeta M Bhorade; Steven R White
Journal:  Respir Res       Date:  2011-04-10

7.  Oral encapsulated transforming growth factor β1 reduces endogenous levels: Effect on inflammatory bowel disease.

Authors:  Laura Hammer; Stacia Furtado; Edith Mathiowitz; Dominick L Auci
Journal:  World J Gastrointest Pharmacol Ther       Date:  2020-11-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.